Skip to content

A study of symptoms , Brain scan findings,and risk of repeat paralysis, in people with blocked or narrowed brain arteries

Clinical presentation, Neuroimaging features and Stroke recurrence in Intracranial Atherosclerotic Disease: A Prospective Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/111978
Enrollment
190
Registered
2026-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I672- Cerebral atherosclerosis

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Datta Meghe Institute of Higher Education And Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adult patients (age more than 18 years) of either sex 2.Clinical diagnosis of acute ischemic stroke in last 30 days confirmed by neuroimaging (CT or MRI brain) 3.Symptom onset within 7 days of presentation 4.Neuroimaging (Computed Tomography Angiography or Magnetic Resonance Angiography) demonstrating 50 to 99 percent stenosis of a major intracranial artery (Intracranial Internal Carotid Artery, M1 segment of Middle Cerebral Artery, Intracranial Vertebral Arteries or Basilar Artery). 5.Symptomatic qualifying stenosis (i.e., located in the arterial territory corresponding to the clinical symptoms and infarct). 6.Ability of the patient or their legally authorized representative to provide written informed consent. 7.Ability to comply with follow-up visits (either in-person or via telephonic contact)

Exclusion criteria

Exclusion criteria: 1.Hemorrhagic stroke (intracerebral hemorrhage, subarachnoid hemorrhage) 2.Stroke secondary to venous sinus thrombosis 3.Stroke due to non-atherosclerotic vasculopathy (vasculitis, moyamoya disease, arterial dissection, fibromuscular dysplasia) 4.Previous endovascular (stenting, angioplasty) or surgical (bypass) treatment of the qualifying artery. 5.Patients with contraindications to CT angiography or MR angiography (severe renal dysfunction with eGFR more than 30 ml per min per 1.73 meter square, contrast allergy, claustrophobia, metallic implants for MRI) 6.Patients with concurrent life-threatening illness (advanced malignancy, end-stage organ failure) with life expectancy less than 6 months

Design outcomes

Primary

MeasureTime frame
Recurrent ischemic stroke within 3 months, defined as new focal neurological deficit of presumed vascular origin lasting more than 24 hours, occurring more than 24 hours after index stroke, with neuroimaging confirmation of new infarctTimepoint: At admission,Day 7,1 month and 3 months

Secondary

MeasureTime frame
Any stroke (ischemic or hemorrhagic) at 3 months Functional outcome: mRS at 3 months (Good outcome: mRS 0-2; Poor outcome: mRS 3-6) Mortality at 3 months Combined vascular events (stroke, MI, vascular death) Timepoint: At admission,Day 7,1 month & 3 months

Countries

India

Contacts

Public ContactDr Tushar Patil

Datta Meghe Institute Of Higher Education

tushar.neuro@gmail.com9021810293

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026